The Transthoracic Impedance Cardiogram Is a Potential Haemodynamic Sensor for an Automated External Defibrillator
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Impedance Cardiography Versus Echocardiography
Journal of Perinatology (2013) 33, 675–680 & 2013 Nature America, Inc. All rights reserved 0743-8346/13 www.nature.com/jp ORIGINAL ARTICLE Noninvasive cardiac monitoring in pregnancy: impedance cardiography versus echocardiography J Burlingame1, P Ohana2, M Aaronoff1 and T Seto3 OBJECTIVE: The objective of this study was to report thoracic impedance cardiography (ICG) measurements and compare them with echocardiography (echo) measurements throughout pregnancy and in varied maternal positions. METHOD: A prospective cohort study involving 28 healthy parturients was performed using ICG and echo at three time points and in two maternal positions. Pearson’s correlations, Bland–Altman plots and paired t-tests were used for statistical analysis. RESULT: Significant agreements between many but not all ICG and echo contractility, flow and resistance measurements were demonstrated. Differences in stroke volume (SV) due to maternal position were also detected by ICG in the antepartum (AP) period. Significant trends were observed by ICG for cardiac output and thoracic fluid content (TFC; Po0.025) with advancing pregnancy stages. CONCLUSION: ICG and echo demonstrate significant correlations in some but not all measurements of cardiac function. ICG has the ability to detect small changes in SV associated with maternal position change. ICG measurements reflected maximal cardiac contractility in the a AP period yet reflected a decrease in contractility and an increase in TFC in the postpartum period. Journal of Perinatology (2013) 33, 675–680; doi:10.1038/jp.2013.35; -
The Stroke Volume and the Cardiac Output by the Impedance Cardiography
U.P.B. Sci. Bull., Series C, Vol. 74, Iss. 3, 2012 ISSN 1454-234x THE STROKE VOLUME AND THE CARDIAC OUTPUT BY THE IMPEDANCE CARDIOGRAPHY M. C. IPATE1, A. A. DOBRE2, A. M. MOREGA3 Acest studiu este despre impedanţa cardiacă, utilizată pentru determinarea volumul sanguin, pompat de vetricul stang la o singura contractie a inimii, şi a debitul cardiac. În majoritatea articolelor privind acest subiect, persoanele participante la experiment prezintă probleme cardiace. Din acest motiv au fost efectuate teste atât pe subiecţi sănătoşi cât şi pe subiecţi diagnosticaţi cu afecţiuni cardiace. Se urmăreşte compararea rezultatelor obţinute pentru volumul sanguin şi pentru debitul cardiac pentru cele două categorii de persoane, prin două metode ce vor fi detaliate în lucrare. Studiul este completat de rezultate de simulare numerică pentru ICG realizate pe un domeniu de calcul obţinut prin tehnici de imagistică medicală. This study is concerned with the noninvasive impedance cardiography (ICG) as a measure of the stroke volume and cardiac output. In many articles on this topic, people who participate in the experiments have various heart diseases and therefore we did tests on both healthy and with different cardiac disease subjects. The aim is to compare the results obtained for stroke volume and cardiac output for the two categories of persons by two methods, which will be detailed in the paper. A numerical simulation approach to ICG based on a computational domain built out of medical images completes the study. Keywords: impedance cardiography, cardiac output, stroke volume, numerical simulation, finite element, medical imaging 1. Introduction Studies about the impedance cardiography were introduced more than 50 years ago as a noninvasive technique for measuring systolic time intervals and cardiac output4 [1]. -
ICG Impedance Cardiography Non-Invasive Hemodynamic Measurements Impedance Cardiography
Clinical Measurements ICG Impedance Cardiography Non-invasive hemodynamic measurements Impedance Cardiography The technology behind ICG • Detects B, C, and X points on the ICG waveform, Impedance cardiography (ICG) is a safe, non-invasive timed with the vECG method to measure a patient’s hemodynamic status. • Adjusts for patient gender, height, weight, and age The ICG waveform is generated by thoracic electrical • Accepts or rejects each beat bioimpedance (TEB) technology, which measures the level of change in impedance in the thoracic fluid. Four small sensors send and receive a low amplitude electrical current through the thorax to detect the level of change in resistance in the thoracic fluid. With each cardiac cycle, fluid levels change, which affects the impedance to the electrical signal transmitted by the sensors. Advanced ICG algorithm Philips ICG uses a sophisticated algorithm to determine the level of change in impedance, to generate the ICG wave, and to calculate or derive hemodynamic parameters. This advanced algorithm: O Mitral Valve Opens, Ventricular Filling • Removes pacemaker spikes and respiratory artifact B Aortic Valve Opens • Stores an adaptive mean curve as representative of C Peak Systolic Flow X Aortic Valve Closes typical curve shape • Holds three heart beats of current patient data, as SV Stroke Volume VET Ventricular Ejection Time typical for that patient P Atrial systole B-C Slope Acceleration cardiac index ICG sensor placement for impedance cardiography • Two sensors placed above the clavicle on each side -
Public Access Defibrillation/AED Program Implementation Guide
Public Access Defibrillation/AED Program Implementation Guide There are 4 key elements to establishing a Public Access Defibrillation program. These include: Having designated rescuers trained in CPR and in how to use an automated external defibrillator (AED) Having a physician to provide medical oversight and direction Integrating your program with the local emergency medical services (EMS) system Using and maintaining the AED(s) according to the manufacturers specifications Steps: 1. Gain consensus Within your company or organization begin to identify the key decision makers and arrange a meeting to gain support. The American Heart Association or your local EMS Agency can assist you with presentation materials. 2. Review the law and regulations Review Federal, State and local laws and regulations regarding Public Access Defibrillation program requirements. Consult your local Emergency Medical Services (EMS) Agency The California laws ang regulations that pertain to AEDs are Title 22, and AB 658. 3. Consult your local Emergency Medical Services (EMS) Agency The local EMS Agency can provide you with information regarding training, purchasing AEDs, medical direction and laws and regulations. 4. Identify your response team Identify who would be most likely to respond in an emergency – this will help determine how and where AEDs are mounted or stored. 5. Select equipment and vendor Some considerations in selecting the AED may include: Reputation of the AED manufacturer for the product’s quality and customer service, compatibility with the equipment used in the local EMS system, and ease of operation of the AED. 6. Design Policies and Procedures These may include: Who manages the AED program When the AED should be used, when it should not be used Training required to use the AED Locations of AEDs and other equipment (such as gloves and pocket mask for CPR) Notification process for internal AED responders and external emergency medical services responders Maintenance schedule for equipment Training and refresher training policies 7. -
Monitoring Device with Signals Recording on PCMCIA Memory Cards
Pol J Med Phys Eng 2005;11(3):127-209. PL ISSN 1425-4689 Gerard Cybulski Dynamic Impedance Cardiography — the system and its applications Department of Applied Physiology Medical Research Centre Polish Academy of Sciences Warsaw 2005 http://rcin.org.pl In preparing this dissertation use has been made of data from the following papers: Cybulski G, Ksiazkiewicz A, Łukasik W, Niewiadomski W, Palko T. Central hemodynamics and ECG ambulatory monitoring device with signals recording on PCMCIA memory cards. Medical & Biol Engin and Computing 1996; 34(Suppl.1, Part 1): 79-80. Cybulski G, Ziolkowska E, Kodrzycka A, Niewiadomski W, Sikora K, Ksiazkiewicz A, Lukasik W, Palko T. Application of Impedance Cardiography Ambulatory Monitoring System for Analysis of Central Hemodynamics in Healthy Man and Arrhythmia Patients. Computers in Cardiology 1997. (Cat. No.97CH36184). IEEE. 1997, pp.509-12. New York, NY, USA. Cybulski G, Ksiazkiewicz A, Lukasik W, Niewiadomski W, Kodrzycka A, Palko T. Analysis of central hemodynamics variability in patients with atrial fibrillation using impedance cardiography ambulatory monitoring device (reomonitor). Medical & Biol. Engin. and Computing 1999; 37(Suppl.1): 169-170. Cybulski G, Ziolkowska E, Ksiazkiewicz A, Lukasik W, Niewiadomski W, Kodrzycka A, Palko T. Application of Impedance Cardiography Ambulatory Monitoring Device for Analysis of Central Hemodynamics Variability in Atrial Fibrillation. Computers in Cardiology 1999. Vol. 26 (Cat. No.99CH37004). IEEE. 1999, pp. 563-6. Piscataway, NJ, USA. Cybulski G, Michalak E, Kozluk E, Piatkowska A, Niewiadomski W. Stroke volume and systolic time intervals: beat-to-beat comparison between echocardiography and ambulatory impedance cardiography in supine and tilted positions. -
Delaying Defibrillation to Give Basic Cardiopulmonary Resuscitation to Patients with Out-Of-Hospital Ventricular Fibrillation a Randomized Trial
ORIGINAL CONTRIBUTION Delaying Defibrillation to Give Basic Cardiopulmonary Resuscitation to Patients With Out-of-Hospital Ventricular Fibrillation A Randomized Trial Lars Wik, MD, PhD Context Defibrillation as soon as possible is standard treatment for patients with ven- Trond Boye Hansen tricular fibrillation. A nonrandomized study indicates that after a few minutes of ven- Frode Fylling tricular fibrillation, delaying defibrillation to give cardiopulmonary resuscitation (CPR) first might improve the outcome. Thorbjørn Steen, MD Objective To determine the effects of CPR before defibrillation on outcome in pa- Per Vaagenes, MD, PhD tients with ventricular fibrillation and with response times either up to or longer than Bjørn H. Auestad, PhD 5 minutes. Design, Setting, and Patients Randomized trial of 200 patients with out-of- Petter Andreas Steen, MD, PhD hospital ventricular fibrillation in Oslo, Norway, between June 1998 and May 2001. ARLY DEFIBRILLATION IS CRITICAL Patients received either standard care with immediate defibrillation (n=96) or CPR first for survival from ventricular fi- with 3 minutes of basic CPR by ambulance personnel prior to defibrillation (n=104). If initial defibrillation was unsuccessful, the standard group received 1 minute of CPR brillation. The survival rate de- before additional defibrillation attempts compared with 3 minutes in the CPR first group. creases by 3% to 4% or 6% to E10% per minute depending on whether Main Outcome Measure Primary end point was survival to hospital discharge. Sec- ondary end points were hospital admission with return of spontaneous circulation (ROSC), basic cardiopulmonary resuscitation 1,2 1-year survival, and neurological outcome. A prespecified analysis examined sub- (CPR) is performed. -
The Refractory VF Arrest Patient: a Review of the Current Treatment
1/24/2018 The Refractory VF Arrest Patient: A Review of the Current Treatment Options Marc Conterato, MD, FACEP Office of the Medical Director North Memorial Health Ambulance Service DISCLOSURE STATEMENT • Board Member, MN Resuscitation Consortium - Images of any commercial devices or medications are for illustration purposes only. The inclusion of such images in this presentation does not imply endorsement of any specific device or company. 2 Objectives • Delineate Refractory Ventricular Fibrillation (RVF) • Recurrent VF versus Refractory VF • What is “Electrical Storm” • Current Pre-hospital treatments • Additional hospital treatments • Dual/Double Sequential Defibrillation • ECMO/ECLS-A New Hope? 3 1 1/24/2018 A Standard Scenario • 55 YOF collapses at stop light, and her car rolls into the car in front of her. Airbags do not deploy, and bystanders find her slumped over the steering wheel and pulseless. • First responder/bystanders start CPR, and deliver three AED shocks prior to EMS arrival. • On EMS arrival, a fourth shock is delivered, an IO and alternative airway placed. Automated CPR started. • Epinephrine 2 mg (total) and Amiodarone 300 mg given, and the patient remains in VF. • Patient downtime is now ~25 minutes, and repeat evaluation reveals persistent VF. 4 What are your options • Continue CPR for a total of 30 minutes with recurrent defibrillations, additional epinephrine, bicarbonate and Amiodarone? • “Load and Go” to the local hospital with CPR enroute and continuing the resuscitation? • “Load and Go” to the local CCL (Cardiac Cath Lab) hospital with CPR enroute and continuing the resuscitation, with possible PCI with ongoing CPR? • Call HEMS unit for transfer to CCL hospital, but can they continue effective CPR in the helicopter? • “Load and Go” to a ECMO/ECLS center with CPR enroute and continuing the resuscitation, on the basis they can accept the patient and continue resuscitation? 5 Defining the problem: What is recurrent versus refractory VF (RVF)? • Recurrent VF is a rhythm that terminates with cardioversion, but then recurs rapidly. -
Impedance Cardiography
Impedance Cardiography Client: Professor Webster Advisor: Mr. Amit Nimunkar Leader: Jacob Meyer Communicator: David Schreier BSAC: Tian Zhao BWIG: Ross Comer I. Problem Statement Current methods for measuring cardiac output are invasive. Impedance Cardiography is a non-invasive medical procedure utilized in order to properly analyze and depict the flow of blood through the body. With this technique, four electrodes are attached to the body—two on the neck and two on the chest—which take beat by beat measurements of blood volume and velocity changes in the aorta. However, our client hypothesizes that the current method withholds degrees of inaccuracy due to the mere fact that the electrodes are placed too far from the heart. The goal of this project is to design an accurate, reusable, spatially specific system that ensures more accurate and reliable cardiographic readings. Furthermore, this system must produce consistent results able to be accurately interpreted by industry professionals. More specifically, this semester our precise goal is to begin experimental impedance testing on human subjects using an electrode array, placing electrodes directly over the aorta, and using a custom circuit to filter out our signal. II. Background It is frequently necessary in the hospital setting to assess the state of a patient’s circulation. Here the determination of simple measurements, such as heart rate and blood pressure, may be adequate for most patients, but if there is a cardiovascular condition such as sepsis or cardiomyopathy then a more detailed approach is needed. In order to non-invasively gather specific measurements on the volume of blood pumped by the heart (cardiac output) through the aorta, the technique of impedance cardiography can be used [3]. -
Resuscitation and Defibrillation
AARC GUIDELINE: RESUSCITATION AND DEFIBRILLATION AARC Clinical Practice Guideline Resuscitation and Defibrillation in the Health Care Setting— 2004 Revision & Update RAD 1.0 PROCEDURE: signs, level of consciousness, and blood gas val- Recognition of signs suggesting the possibility ues—included in those conditions are or the presence of cardiopulmonary arrest, initia- 4.1 Airway obstruction—partial or complete tion of resuscitation, and therapeutic use of de- 4.2 Acute myocardial infarction with cardio- fibrillation in adults. dynamic instability 4.3 Life-threatening dysrhythmias RAD 2.0 DESCRIPTION/DEFINITION: 4.4 Hypovolemic shock Resuscitation in the health care setting for the 4.5 Severe infections purpose of this guideline encompasses all care 4.6 Spinal cord or head injury necessary to deal with sudden and often life- 4.7 Drug overdose threatening events affecting the cardiopul- 4.8 Pulmonary edema monary system, and involves the identification, 4.9 Anaphylaxis assessment, and treatment of patients in danger 4.10 Pulmonary embolus of or in frank arrest, including the high-risk de- 4.11 Smoke inhalation livery patient. This includes (1) alerting the re- 4.12 Defibrillation is indicated when cardiac suscitation team and the managing physician; (2) arrest results in or is due to ventricular fibril- using adjunctive equipment and special tech- lation.1-5 niques for establishing, maintaining, and moni- 4.13 Pulseless ventricular tachycardia toring effective ventilation and circulation; (3) monitoring the electrocardiograph and recogniz- -
Impact of Impedance Cardiography on Diagnosis and Therapy of Emergent Dyspnea: the ED-IMPACT Trial
CLINICAL INVESTIGATIONS Impact of Impedance Cardiography on Diagnosis and Therapy of Emergent Dyspnea: The ED-IMPACT Trial W. Frank Peacock, MD, Richard L. Summers, MD, Jody Vogel, MD, Charles E. Emerman, MD Abstract Background: Dyspnea is one of the most common emergency department (ED) symptoms, but early diag- nosis and treatment are challenging because of multiple potential causes. Impedance cardiography (ICG) is a noninvasive method to measure hemodynamics that may assist in early ED decision making. Objectives: To determine the rate of change in working diagnosis and initial treatment plan by adding ICG data during the course of ED clinical evaluation of elder patients presenting with dyspnea. Methods: The authors studied a convenience sample of dyspneic patients 65 years and older who were presenting to the EDs of two urban academic centers. The attending emergency physician was initially blinded to the ICG data, which was collected by research staff not involved in patient care. At initial ED presentation, after history and physical but before central lab or radiograph data were returned, the at- tending ED physician completed a case report form documenting diagnosis and treatment plan. The phy- sician then was shown the ICG data and the same information was again recorded. Pre- and post-ICG differences were analyzed. Results: Eighty-nine patients were enrolled, with a mean age of 74.8 Æ 7.0 years; 52 (58%) were African American, 42 (47%) were male. Congestive heart failure and chronic obstructive pulmonary disease were the most common final diagnoses, occurring in 43 (48%), and 20 (22%), respectively. ICG data changed the working diagnosis in 12 (13%; 95% CI = 7% to 22%) and medications administered in 35 (39%; 95% CI = 29% to 50%). -
PUBLIC ACCESS to AUTOMATED EXTERNAL DEFIBRILLATORS (Aeds) FACTS
POSITION STATEMENT PUBLIC ACCESS TO AUTOMATED EXTERNAL DEFIBRILLATORS (AEDs) FACTS • Cardiac refers to the heart. Arrest means stop. Sudden cardiac arrest is the sudden and unexpected loss of heart function. • Signs of cardiac arrest include: no breathing or only gasping, no movement, and no pulse. • Up to 40,000 cardiac arrests occur each year in Canada. That’s one cardiac arrest every 12 minutes. Without rapid and appropriate treatment, most of these cardiac arrests will result in death. Thousands of lives could be saved through public access to automated external defibrillators. • An automated external defibrillator (AED) is a small, portable device used to identify cardiac rhythms and deliver a shock to correct abnormal electrical activity in the heart. As a result of the sophisticated electronics in an AED the operator will only be advised to deliver a shock if the • A landmark study of the City of Chicago airports public heart is in a rhythm which can be corrected by defibrillation. access to AED program showed survival rates as high as If a shockable rhythm is not detected, no shock can be 75%. This success is directly related to highly visible, readily given and the provider will be instructed to perform accessible automated external defibrillators for public use cardiopulmonary resuscitation (CPR) until emergency and an integrated structured emergency response system.7 medical services arrive. • Research shows that AEDs are most effectively used by • When an AED and CPR are immediately available, the trained individuals. However, AEDs are safe and easy to use chance of survival from sudden cardiac arrest is substantially by almost anyone. -
Sudden Cardiac Arrest a Treatable Public Health Crisis Ê Ê
Sudden Cardiac Arrest A Treatable Public Health Crisis Table of Contents Overview Part I: Medical Issues Definition and Incidence of Sudden Cardiac Arrest Treatment of Sudden Cardiac Arrest The Evolution of Rapid Emergency Defibrillation Part II: Economic Issues Part III: Technology Issues The Automatic External Defibrillator (AED) Breakthrough AED Technology: Key Criteria Part IV: The Ultimate Goal—Rapid And Effective Response Summary and Conclusions Glossary References "Sudden Cardiac Arrest: A Treatable Public Health Crisis" was written under an educational grant from Heartstream, Inc. by Communicore, an independent medical communications organization. It is one White Paper in a series published by Communicore to explore emerging issues in healthcare, generate awareness about these topics, and facilitate discussion about possible solutions. For more information about this or any other Communicore product or service e-mail: [email protected]. Copyright © 1996, Communicore, 2 Union Square, 601 Union Street, Suite 4600, Seattle, WA 98101 USA. Any reproduction without permission is prohibited. Overview Sudden cardiac arrest (SCA) remains a major unresolved public health problem; each year in the United States alone, sudden cardiac arrest strikes more than 350,000 people—nearly 1,000 per day—making it the single leading cause of death.1,2 Due in part to the unexpectedness with which SCA strikes, most of these victims die before reaching a hospital. Currently, the chances of surviving an SCA in the United States are less than one in 20. Experts agree that many of the deaths due to SCA are preventable and that available technology, if appropriately applied, could reduce them significantly at a relatively low cost.3 The vast majority of sudden cardiac arrests are due to abnormal heart rhythms called arrhythmias, of which ventricular fibrillation is the most common.